A detailed history of Rock Springs Capital Management LP transactions in Novavax Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 675,000 shares of NVAX stock, worth $6.31 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
675,000
Previous 537,625 25.55%
Holding current value
$6.31 Million
Previous $2.57 Million 232.62%
% of portfolio
0.26%
Previous 0.07%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $534,388 - $2.88 Million
137,375 Added 25.55%
675,000 $8.55 Million
Q4 2023

Feb 14, 2024

SELL
$4.8 - $7.67 $528,360 - $844,275
-110,075 Reduced 16.99%
537,625 $2.58 Million
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $755,910 - $1.08 Million
111,000 Added 20.68%
647,700 $4.69 Million
Q2 2023

Aug 14, 2023

BUY
$6.67 - $9.52 $8,671 - $12,376
1,300 Added 0.24%
536,700 $3.99 Million
Q1 2023

May 15, 2023

BUY
$5.76 - $12.48 $16,128 - $34,944
2,800 Added 0.53%
535,400 $3.71 Million
Q4 2022

Feb 14, 2023

SELL
$8.86 - $25.04 $590,962 - $1.67 Million
-66,700 Reduced 11.13%
532,600 $5.48 Million
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $2.26 Million - $9.45 Million
124,200 Added 26.14%
599,300 $10.9 Million
Q2 2022

Aug 15, 2022

BUY
$36.28 - $75.29 $975,932 - $2.03 Million
26,900 Added 6.0%
475,100 $24.4 Million
Q1 2022

May 16, 2022

BUY
$69.73 - $142.9 $1.62 Million - $3.32 Million
23,200 Added 5.46%
448,200 $33 Million
Q4 2021

Feb 14, 2022

SELL
$134.56 - $217.97 $4.04 Million - $6.54 Million
-30,000 Reduced 6.59%
425,000 $60.8 Million
Q2 2021

Aug 16, 2021

SELL
$121.0 - $257.67 $726,000 - $1.55 Million
-6,000 Reduced 1.3%
455,000 $96.6 Million
Q1 2021

May 17, 2021

SELL
$112.98 - $319.93 $11.5 Million - $32.7 Million
-102,205 Reduced 18.15%
461,000 $83.6 Million
Q4 2020

Feb 16, 2021

SELL
$78.74 - $139.5 $1.77 Million - $3.14 Million
-22,500 Reduced 3.84%
563,205 $62.8 Million
Q3 2020

Nov 16, 2020

BUY
$79.44 - $178.51 $1.2 Million - $2.7 Million
15,107 Added 2.65%
585,705 $63.5 Million
Q2 2020

Aug 14, 2020

BUY
$13.86 - $83.61 $7.91 Million - $47.7 Million
570,598 New
570,598 $47.6 Million
Q4 2019

Feb 14, 2020

SELL
$3.69 - $5.22 $599,625 - $848,250
-162,500 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$4.93 - $12.2 $801,125 - $1.98 Million
162,500 New
162,500 $952,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.